Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer

Medical Care

Volumn 52, Issue 5, 2014, Pages

  Allen, Larry A ^a   Yood, Marianne Ulcickas ^b,c   Wagner, Edward H ^d   Aiello Bowles, Erin J ^d   Pardee, Roy ^d   Wellman, Robert ^d   Habel, Laurel ^e   Nekhlyudov, Larissa ^f,g   Davis, Robert L ^h   Onitilo, Adedayo A ^g,i   Magid, David J ^j  

^a UNIVERSITY OF COLORADO   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d CENTER FOR HEALTH STUDIES   (United States)

^e DIVISION OF RESEARCH   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g Department of Medicine Harvard Vanguard Medical ^*  (United States)

^h Center for Health Research Southeast Kaiser Permanente Georgia   (United States)

ⁱ MARSHFIELD CLINIC   (United States)

^j KAISER PERMANENTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; TRASTUZUMAB;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CARDIAC IMAGING; CARDIOMYOPATHY; CARDIOTOXICITY; CODING ALGORITHM; GOLD STANDARD; HEALTH CARE SYSTEM; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; ICD-9; MAJOR CLINICAL STUDY; MEDICAL RECORD; PERFORMANCE; PREDICTIVE VALUE; PRIORITY JOURNAL; TUMOR VOLUME;

AGED; ALGORITHMS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARDIOMYOPATHIES; CLINICAL CODING; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; INSURANCE CLAIM REVIEW; MIDDLE AGED; PREVALENCE; REPRODUCIBILITY OF RESULTS; STROKE VOLUME;

EID: 84898460927     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0b013e31825a8c22     Document Type: Article

References (25)

1. Felker GM, Adams KF Jr, Konstam MA, et al. The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J. 2003;145(suppl):S18-S25.
2. Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol. 2009;53:2231-2247.
3. Jones LW, Haykowsky MJ, Swartz JJ, et al. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol. 2007;50:1435-1441.
4. Smith LA, Cornelius VR, Plummer CJ, et al. Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC Cancer. 2010;10:337.
5. Romond EH, Perez EA, Bryant J, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med. 2005;353:1673-1684.
6. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med. 2005;353:1659-1672.
7. Joensuu H, Kellokumpu-Lehtinen PL, Bono P, et al. Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer. N Engl J Med. 2006;354:809-820.
8. Kurian AW, Fish K, Shema SJ, et al. Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res. 2011;12:R99.
9. Slamon D, Eiermann W, Robert N, et al. Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med. 2011;365:1273-1283.
10. Gross CP, Steiner CA, Bass EB, et al. Relation between prepublication release of clinical trial results and the practice of carotid endarterectomy. JAMA. 2000;284:2886-2893.
11. Ruo B, Capra AM, Jensvold NG, et al. Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study. J Am Coll Cardiol. 2004;43:429-435.
12. Go AS, Yang J, Ackerson LM, et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation. 2006;113: 2713-2723.
13. Go AS, Lee WY, Yang J, et al. Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA. 2006;296:2105-2111.
14. Lee DS, Donovan L, Austin PC, et al. Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care. 2005;43:182-188.
15. Kumler T, Gislason GH, Kirk V, et al. Accuracy of a heart failure diagnosis in administrative registers. Eur J Heart Fail. 2008;10: 658-660.
16. Doyle JJ, Neugut AI, Jacobson JS, et al. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. J Clin Oncol. 2005;23:8597-8605.
17. Pinder MC, Duan Z, Goodwin JS, et al. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol. 2007;25:3808-3815.
18. Du XL, Xia R, Liu CC, et al. Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer. Cancer. 2009;115:5296-5308.
19. Portera CC, Swain SM. The heart of the matter. J Clin Oncol. 2007;25:3794-3796.
20. Wagner EH, Greene SM, Hart G, et al. Building a research consortium of large health systems: the Cancer Research Network. J Natl Cancer Inst Monogr. 2005:3-11. PMID: 16287880.
21. Delate T, Aiello Bowles E, Pardee T, et al. Validity of HMO administrative data for breast cancer chemotherapy exposure. Paper presented at: 17th Annual HMO Research Network Conference, 2011, Boston, MA.
22. Hendel RC, Budoff MJ, Cardella JF, et al. ACC/AHA/ACR/ASE/ASNC/ HRS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SIR 2008 Key Data Elements and Definitions for Cardiac Imaging: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Cardiac Imaging. Circulation. 2009;119:154-186.
23. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388-2442.
24. Horvitz DG, Thompson DJ. A generalization of sampling without replacement from a finite universe. J Am Stat Assoc. 1952;47:663-685.
25. McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971; 285:1441-1446.